FDA issues warning on OTC 'homeopathic' asthma products

The FDA is warning consumers not to rely on asthma products sold over-the-counter and labeled as homeopathic because the agency has not evaluated these products for safety or efficacy, according to a press release.....

Read more here: healio.com

------------------------------------------------------

Study: 1 in 4 Newark children has asthma; EPA steps in for air quality testing

NEWARK (WABC) --
A new study shows an alarmingly high number of children in Newark with asthma, and now, the Environmental Protection Agency is stepping in with sensors that measure air pollution.....

Read more here: 7online.com

------------------------------------------------------

Stratification of patients with severe asthma

Increased eosinophil counts have been recognised to be linked to asthma severity and are a risk factor for asthma exacerbations. Therefore, decreasing eosinophil count by targeting the interleukin-5-mediated signalling pathway could help to reduce airway inflammation and improve asthma treatment control. In The Lancet Respiratory Medicine, Mario Castro and colleagues1 report data from two large, randomised, placebo-controlled trials, in which reslizumab, a neutralising monoclonal antibody for interleukin 5, was safe and effective in patients with severe eosinophilic asthma.....

Read more here: thelancet.com